Article
Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells.
Cancer research - 15 Aug 2005
Shalom-Feuerstein Ruby, Cooks Tomer, Raz Avraham, Kloog Yoel
Abstract excerpt
Galectin-3 (Gal-3), a pleiotropic carbohydrate-binding protein, is a selective binding partner of activated K-Ras-GTP. Because both proteins are antiapoptotic and associated with cancer progression, we questioned the possible functional role of Gal-3 in K-Ras activation. We found that overexpression of Gal-3 in human breast cancer cells (BT-549/Gal-3) coincided with a significant increase in wild-type (wt)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
